Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
3(19%)
Results Posted
13%(1 trials)

Phase Distribution

Ph phase_3
1
6%
Ph phase_4
1
6%
Ph phase_1
1
6%
Ph phase_2
3
19%
Ph not_applicable
10
63%

Phase Distribution

1

Early Stage

3

Mid Stage

2

Late Stage

Phase Distribution16 total trials
Phase 1Safety & dosage
1(6.3%)
Phase 2Efficacy & side effects
3(18.8%)
Phase 3Large-scale testing
1(6.3%)
Phase 4Post-market surveillance
1(6.3%)
N/ANon-phased studies
10(62.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

8 of 10 finished

Non-Completion Rate

20.0%

2 ended early

Currently Active

3

trials recruiting

Total Trials

16

all time

Status Distribution
Active(3)
Completed(8)
Terminated(2)
Other(3)

Detailed Status

Completed8
unknown3
Withdrawn2
Recruiting2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
16
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (6.3%)
Phase 23 (18.8%)
Phase 31 (6.3%)
Phase 41 (6.3%)
N/A10 (62.5%)

Trials by Status

withdrawn213%
active_not_recruiting16%
recruiting213%
completed850%
unknown319%

Recent Activity

3 active trials
Showing 5 of 16
completedphase_2

Maternal Probiotic Intervention to Improve Gut Health

NCT05922683
active_not_recruitingnot_applicable

Effects of a Probiotic in Hypertension

NCT03906578
recruitingphase_2

Preventive Effect of Perinatal Oral Probiotic Supplementation (POPS) on Neonatal Jaundice

NCT06087874
completednot_applicable

Impact of Probiotics in HIV-positive Patients With Neurocognitive Disorders

NCT04175223
recruitingnot_applicable

Effects of a Combined Supplementation of Conjugated Linoleic Acid (CLA) and Probiotics (Vivomixx®) as add-on to a First-line Immunotherapy in Relapsing-remitting Multiple Sclerosis

NCT05920018
View all 16 trials

Clinical Trials (16)

Showing 16 of 16 trials
NCT05922683Phase 2

Maternal Probiotic Intervention to Improve Gut Health

Completed
NCT03906578Not Applicable

Effects of a Probiotic in Hypertension

Active Not Recruiting
NCT06087874Phase 2

Preventive Effect of Perinatal Oral Probiotic Supplementation (POPS) on Neonatal Jaundice

Recruiting
NCT04175223Not Applicable

Impact of Probiotics in HIV-positive Patients With Neurocognitive Disorders

Completed
NCT05920018Not Applicable

Effects of a Combined Supplementation of Conjugated Linoleic Acid (CLA) and Probiotics (Vivomixx®) as add-on to a First-line Immunotherapy in Relapsing-remitting Multiple Sclerosis

Recruiting
NCT06196450Phase 2

Maternal Probiotic Intervention to Improve Gut Health

Unknown
NCT03369431Not Applicable

Efficacy of Vivomixx on Behaviour and Gut Function in Autism Spectrum Disorder

Completed
NCT02957591Not Applicable

Probiotic Supplementation in Severe Depression

Completed
NCT03109587Not Applicable

Pilot Study of Probiotics in Pre-diabetic Adolescents

Completed
NCT02508844Phase 4

Effect of Probiotics (Vivomixx®) on Weight, Microbiota and Glucose Tolerance in Obese Pregnant Women and Their Newborn

Completed
NCT04099433Not Applicable

Application of Oral Bacteriotherapy to Promote Anal HPV Clearance in HIV Positive Individuals

Unknown
NCT03860415Not Applicable

Can Probiotic Vivomixx Eradicate Colonization With ESBL?

Completed
NCT02708901Not Applicable

Gut to Brain Interaction in Autism. Role of Probiotics on Clinical, Biochemical and Neurophysiological Parameters

Completed
NCT03518268Phase 1

Vivomixx for Prevention of Bone Loss in Women With Breast Cancer Treated With an Aromatase Inhibitor

Unknown
NCT03236090Not Applicable

Effect of Vivomixx® on Neuroinflammation in Patients Withs Cirrhosis

Withdrawn
NCT02552862Phase 3

Study of the Effect of Adjunctive Vivomixx® in Patients With Cirrhosis and Spontaneous Bacterial Peritonitis (SBP)

Withdrawn

All 16 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
16